Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Neural Correlates of Abnormal Temporal Discrimination in Unaffected Relatives of Cervical Dystonia Patients.

Narasimham S, McGovern EM, Quinlivan B, Killian O, Beck R, O'Riordan S, Hutchinson M, Reilly RB.

Front Integr Neurosci. 2019 Mar 12;13:8. doi: 10.3389/fnint.2019.00008. eCollection 2019.

2.

Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia.

Xiao W, Goldberg AD, Famulare CA, Devlin SM, Nguyen NT, Sim S, Kabel CC, Patel MA, McGovern EM, Patel A, Schulman J, Dunbar AJ, Epstein-Peterson ZD, Menghrajani KN, Getta BM, Cai SF, Geyer MB, Glass JL, Taylor J, Viny AD, Levine RL, Zhang Y, Giralt SA, Klimek V, Tallman MS, Roshal M.

Haematologica. 2019 Jul;104(7):1378-1387. doi: 10.3324/haematol.2018.203018. Epub 2018 Dec 6.

3.

The expanding spectrum of paroxysmal movement disorders: update from clinical features to therapeutics.

McGovern EM, Roze E, Counihan TJ.

Curr Opin Neurol. 2018 Aug;31(4):491-497. doi: 10.1097/WCO.0000000000000576. Review.

PMID:
29771692
4.

Measurement & Analysis of the Temporal Discrimination Threshold Applied to Cervical Dystonia.

Beck RB, McGovern EM, Butler JS, Birsanu D, Quinlivan B, Beiser I, Narasimham S, O'Riordan S, Hutchinson M, Reilly RB.

J Vis Exp. 2018 Jan 27;(131). doi: 10.3791/56310.

PMID:
29443021
5.

Health-Related Quality of Life Is Severely Affected in Primary Orthostatic Tremor.

Maugest L, McGovern EM, Mazalovic K, Doulazmi M, Apartis E, Anheim M, Bourdain F, Benchetrit E, Czernecki V, Broussolle E, Bonnet C, Falissard B, Jahanshahi M, Vidailhet M, Roze E.

Front Neurol. 2018 Jan 15;8:747. doi: 10.3389/fneur.2017.00747. eCollection 2017.

6.

Temporal Discrimination: Mechanisms and Relevance to Adult-Onset Dystonia.

Conte A, McGovern EM, Narasimham S, Beck R, Killian O, O'Riordan S, Reilly RB, Hutchinson M.

Front Neurol. 2017 Nov 28;8:625. doi: 10.3389/fneur.2017.00625. eCollection 2017. Review.

7.

The premotor syndrome of cervical dystonia: Disordered processing of salient environmental stimuli.

Hutchinson M, McGovern EM, Narasimham S, Beck R, Reilly RB, Walsh CD, Malone KM, Tijssen MAJ, O'Riordan S.

Mov Disord. 2018 Feb;33(2):232-237. doi: 10.1002/mds.27229. Epub 2017 Dec 4. Review. No abstract available.

PMID:
29205495
8.

Practice does not make perfect: Temporal discrimination in musicians with and without dystonia.

Killian O, McGovern EM, Beck R, Beiser I, Narasimham S, Quinlivan B, O'Riordan S, Simonyan K, Hutchinson M, Reilly RB.

Mov Disord. 2017 Dec;32(12):1791-1792. doi: 10.1002/mds.27185. Epub 2017 Oct 27. No abstract available.

9.

In vivo imaging of translocator protein, a marker of activated microglia, in alcohol dependence.

Hillmer AT, Sandiego CM, Hannestad J, Angarita GA, Kumar A, McGovern EM, Huang Y, O'Connor KC, Carson RE, O'Malley SS, Cosgrove KP.

Mol Psychiatry. 2017 Dec;22(12):1759-1766. doi: 10.1038/mp.2017.10. Epub 2017 Feb 28.

10.

Pseudomonoballismus in a Deafferented Arm Following Combined Medullary and Cerebellar Lesions of the Proprioceptive Pathways.

McGovern EM, Foley M, Looby S, Connolly S, Farrell M, Healy DG.

Mov Disord Clin Pract. 2016 Aug 11;4(3):455-457. doi: 10.1002/mdc3.12417. eCollection 2017 May-Jun. No abstract available.

11.

Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer.

McGovern EM, Lewis ME, Niesley ML, Huynh N, Hoag JB.

Nutr J. 2016 Feb 12;15:17. doi: 10.1186/s12937-016-0135-3.

12.

Tremor severity is a poor predictor of social disability in patients with essential tremor.

Cullinane PW, Browne PJ, Leahy TK, McGovern EM, Counihan TJ.

Parkinsonism Relat Disord. 2014 Nov;20(11):1311-2. doi: 10.1016/j.parkreldis.2014.09.006. Epub 2014 Sep 16. No abstract available.

PMID:
25242805
13.

Antibiotic treatment of urinary tract infection by community pharmacists: a cross-sectional study.

Booth JL, Mullen AB, Thomson DA, Johnstone C, Galbraith SJ, Bryson SM, McGovern EM.

Br J Gen Pract. 2013 Apr;63(609):e244-9. doi: 10.3399/bjgp13X665206.

14.

The effect of B cell receptor signaling on antigen endocytosis and processing.

McGovern EM, Moquin AE, Caballero A, Drake JR.

Immunol Invest. 2004 May;33(2):143-56.

PMID:
15195694
15.

Lactic acidosis after cardiac surgery is associated with polymorphisms in tumor necrosis factor and interleukin 10 genes.

Ryan T, Balding J, McGovern EM, Hinchion J, Livingstone W, Chughtai Z, Smith OP.

Ann Thorac Surg. 2002 Jun;73(6):1905-9; discussion 1910-1.

PMID:
12078789
16.

Pharmaceutical care needs of patients with angina.

McGovern EM, Mackay C, Hair A, Lindsay H, Bryson SM.

Pharm World Sci. 2001 Oct;23(5):175-6.

PMID:
11721671
17.

Streptomycin dose requirements in continuous ambulatory peritoneal dialysis.

McGovern EM, Thomson AH, Bala VR, Subramanian, Rodger RS.

Nephrol Dial Transplant. 1994;9(3):331-2. No abstract available.

PMID:
8052447
18.

Resection of an intracardiac metastasis from malignant teratoma of the testis.

O'Donnell AF, Maghur HA, Grogan L, Carney D, McGovern EM.

Ann Thorac Surg. 1993 Dec;56(6):1386-7.

PMID:
8267441
19.

Fatal trauma: a five year review in a Dublin hospital.

Caldwell MT, McGovern EM.

Ir J Med Sci. 1993 Aug;162(8):309-12.

PMID:
8244652
20.

Gastrointestinal complications after cardiac surgery.

Egleston CV, Wood AE, Gorey TF, McGovern EM.

Ann R Coll Surg Engl. 1993 Jan;75(1):52-6.

21.

Operation for cavitating invasive pulmonary aspergillosis in immunocompromised patients.

Young VK, Maghur HA, Luke DA, McGovern EM.

Ann Thorac Surg. 1992 Apr;53(4):621-4.

PMID:
1554270
22.

Population pharmacokinetics of rectal theophylline in neonates.

Karlsson MO, Thomson AH, McGovern EM, Chow P, Evans TJ, Kelman AW.

Ther Drug Monit. 1991 May;13(3):195-200.

PMID:
1926271
23.

Completion pneumonectomy: indications, complications, and results.

McGovern EM, Trastek VF, Pairolero PC, Payne WS.

Ann Thorac Surg. 1988 Aug;46(2):141-6.

PMID:
3401074
24.

Phenytoin monitoring: clinical or scientific?

Fulton JD, McGovern EM, McCarron BN, Carlile AK.

Scott Med J. 1988 Jun;33(3):267-8.

PMID:
3175605
25.

Population pharmacokinetics of gentamicin in neonates.

Thomson AH, Way S, Bryson SM, McGovern EM, Kelman AW, Whiting B.

Dev Pharmacol Ther. 1988;11(3):173-9.

PMID:
3289859
26.

Theophylline toxicity following coadministration of viloxazine.

Thomson AH, Addis GJ, McGovern EM, McDonald NJ.

Ther Drug Monit. 1988;10(3):359-60. No abstract available.

PMID:
3176117
27.

Evaluation of a new Seralyzer assay for carbamazepine.

McGovern EM, MacRobbie A, Thomson AH, Whiting B.

Ther Drug Monit. 1988;10(3):355-8.

PMID:
3176116
28.

Pharmacokinetics of high-dose metoclopramide in cancer patients.

McGovern EM, Grevel J, Bryson SM.

Clin Pharmacokinet. 1986 Nov-Dec;11(6):415-24. Review.

PMID:
3542335
29.

The pharmacokinetics of high dose metoclopramide in patients with neoplastic disease.

Bryson SM, McGovern EM, Kelman AW, White K, Addis GJ, Whiting B.

Br J Clin Pharmacol. 1985 Jun;19(6):757-66.

30.

Evaluation of a high pressure liquid chromatographic technique for metoclopramide analysis.

Bryson SM, McGovern EM, Gilbert LM.

J Clin Hosp Pharm. 1984 Sep;9(3):263-6.

PMID:
6490946

Supplemental Content

Loading ...
Support Center